Pretreatment with helium does not attenuate liver injury after warm ischemia-reperfusion

Shock

Volumn 41, Issue 5, 2013, Pages 413-419

  Braun, Sebastian ^a   Plitzko, Gabriel ^b   Bicknell, Leonie ^c   Van Caster, Patrick ^a   Schulz, Jan ^a   Barthuber, Carmen ^a   Preckel, Benedikt ^d   Pannen, Benedikt H ^a   Bauer, Inge ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Hepatocellular damage; Ischemic preconditioning; Liver enzymes; Pharmacologic preconditioning

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; HELIUM; HEME OXYGENASE 1; INTERLEUKIN 10; MESSENGER RNA; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; ISCHEMIC PRECONDITIONING; LAPAROTOMY; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NEUTROPHIL; NONHUMAN; OXYGENATION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; TEMPERATURE; ANIMAL; BLOOD; INJURIES; ISCHEMIA; LIVER; REPERFUSION INJURY; WISTAR RAT;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HELIUM; INTERLEUKIN-10; ISCHEMIC PRECONDITIONING; LIVER; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA; WARM ISCHEMIA;

EID: 84925944045     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000125     Document Type: Conference Paper

References (34)

1. Serracino-Inglott F, Habib NA, Mathie RT: Hepatic ischemia-reperfusion injury. Am J Surg 181(2):160-166, 2001.
2. Fondevila C, Busuttil RW, Kupiec-Weglinski JW: Hepatic ischemia/reperfusion injuryVa fresh look. Exp Mol Pathol 74(2):86-93, 2003.
3. González-Flecha B, Cutrin JC, Boveris A: Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. J Clin Invest 91(2):456-464, 1993.
4. Lee SM, Park MJ, Cho TS, Clemens MG: Hepatic injury and lipid peroxidation during ischemia and reperfusion. Shock 13(4):279-284, 2000.
5. Jaeschke H: Mechanisms of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 5(4):402-408, 1998.
6. Jaeschke H, Farhood A: Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 260(3 pt 1):G355-G362, 1991.
7. Wanner GA, Ertel W, Müller P, Höfer Y, Leiderer R, Menger MD, Messmer K: Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation. Shock 5(1):34-40, 1996.
8. Bahde R, Spiegel H-U: Hepatic ischaemia-reperfusion injury from bench to bedside. Br J Surg 97(10):1461-1475, 2010.
9. Lee W-Y, Lee S-M: Ischemic preconditioning protects post-ischemic oxidative damage to mitochondria in rat liver. Shock 24(4):370-375, 2005.
10. Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D, Warltier DC, Pratt Jr. PF: Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signaling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 105(3): 562-569, 2007.
11. Preckel B, Müllenheim J, Moloschavij A, NP, Schlack W: Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 91(6):1327-1332, 2000.
12. Weber NC, Toma O, Wolter JI, Obal D, Müllenheim J, Preckel B, Schlack W: The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK. Br J Pharmacol 144(1): 123-132, 2005.
13. Liu Y, Xue F, Liu G, Shi X, Liu Y, Liu W, Luo X, Sun XJ, Kang ZM: Helium preconditioning attenuates hypoxia/ischemia-induced injury in the developing brain. Brain Res 1376:122-129, 2011.
14. Wilhelm S, Ma D, Maze M, Franks NP: Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 96(6):1485-1491, 2002.
15. Oei GTML, Weber NC, Hollmann MW, Preckel B: Cellular effects of helium in different organs. Anesthesiology 112(6):1503-1510, 2010.
16. Schmidt R, Tritschler E, Hoetzel A, Loop T, Humar M, Halverscheid L, Geiger KK, Pannen BHJ: Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury. Ann Surg 245(6): 931-942, 2007.
17. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9):e45, 2001.
18. Pfaffl MW, Horgan GW, Dempfle L: Relative Expression Software Tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30(9):e36, 2002.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193(1):265-275, 1951.
20. Huhn R, Heinen A, Weber NC, Kerindongo RP, Oei GTML, Hollmann MW, Schlack W, Preckel B: Helium-induced early preconditioning and postconditioning are abolished in obese Zucker rats in vivo. J Pharmacol Exp Ther 329(2):600-607, 2009.
21. Huhn R, Heinen A, Weber NC, Hieber S, Hollmann MW, Schlack W, Preckel B: Helium-induced late preconditioning in the rat heart in vivo. Br J Anaesth 102(5):614-619, 2009.
22. Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A, Ryang YM, Grottke O, Coburn M: Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care13(6):R206, 2009.
23. Smit KF, Oei GTML, Brevoord D, Stroes ES, Nieuwland R, Schlack WS, Hollmann MW, Weber NC, Preckel B: Helium induces preconditioning in human endothelium in vivo. Anesthesiology 118(1):95-104, 2013.
24. Fukuda K, Asoh S, Ishikawa M, Yamamoto Y, Ohsawa I, Ohta S: Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun 361(3): 670-674, 2007.
25. Yun N, Eum H-A, Lee S-M: Protective role of heme oxygenase-1 against liver damage caused by hepatic ischemia and reperfusion in rats. Antioxid Redox Signal 13(10):1503-1512, 2010.
26. Shinoda M, Shimazu M, Wakabayashi G, Tanabe M, Hoshino K, Kitajima M: Tumor necrosis factor suppression and microcirculatory disturbance amelioration in ischemia/reperfusion injury of rat liver after ischemic preconditioning. J Gastroenterol Hepatol 17(11):1211-1219, 2002.
27. Funaki H, Shimizu K, Harada S-I, Tsuyama H, Fushida S, Tani T, Miwa K: Essential role for nuclear factor kappaB in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver. Transplantation 74(4):551-556, 2002.
28. Peralta C, Prats N, Xaus C, Gelpí E, Roselló-Catafau J: Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 30(6):1481-1489, 1999.
29. Serafín A, Roselló-Catafau J, Prats N, Gelpí E, Rodés J, Peralta C: Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 39(3):688-698, 2004.
30. Dinant S, Veteläinen RL, Florquin S, van Vliet AK, van Gulik TM: IL-10 attenuates hepatic I/R injury and promotes hepatocyte proliferation. J Surg Res 141(2):176-182, 2007.
31. Komatsu H, Koo A, Ghadishah E, Zeng H, Kuhlenkamp JF, Inoue M, Guth PH, Kaplowitz N: Neutrophil accumulation in ischemic reperfused rat liver: evidence for a role for superoxide free radicals. Am J Physiol 262(4 pt 1):G669-G676, 1992.
32. Peralta C, Fernández L, Panés J, Prats N, Sans M, Piqué JM, Gelpí E, Roselló-Catafau J: Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factorYinduced P-selectin up-regulation in the rat. Hepatology 33(1):100-113, 2001.
33. Tsuchihashi S, Fondevila C, Kupiec-Weglinski JW: Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant 9(1):84-87, 2004.
34. Sonin NV, Garcia-Pagan JC, Nakanishi K, Zhang JX, Clemens MG: Patterns of vasoregulatory gene expression in the liver response to ischemia/reperfusion and endotoxemia. Shock 11(3):175-179, 1999.